Visualitza HVH - Articles científics per autor "taieb, julien"
Ara mostrant els elements 1-4 d 4
-
First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
Prager, Gerald W; Westphalen, C Benedikt; D'Esquermes, Nathalie; Ferreras, Anabel; Macarulla Mercadé, Teresa; Taieb, Julien; Melisi, Davide (BMJ, 2020-01-20) -
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC
Kopetz, Scott; Bekaii-Saab, Tanios; Elez, Elena; Tabernero, Josep; taieb, julien; Yoshino, Takayuki (Future Science Group, 2024-04) -
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
taieb, julien; Seufferlein, Thomas; Reni, Michele; Palmer, Daniel H.; Cubillo, Antonio; Bridgewater, John; Macarulla, Teresa (BMC, 2023-09-18) -
Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
Tabernero Caturla, Josep; Prager, Gerald W; Leger, Catherine; Fakih, Marwan; Taieb, Julien; Ciardiello, Fortunato (Future Medicine, 2021-06)